Article Versions Notes

Rezende B, Fernandes GG, de Simas Gonçalves VM, Nascimento GG, Marques KL, de Oliveira BCCA, dos Santos YB, de Andrade MEB, Calumbi KS, Maia EP, et al. Cannabigerol Modulates Cannabinoid Receptor Type 2 Expression in the Spinal Dorsal Horn and Attenuates Neuropathic Pain Models. Pharmaceuticals. 2025; 18(10):1508. https://doi.org/10.3390/ph18101508

Rezende, Bismarck, Gabriel Gripp Fernandes, Vitória Macario de Simas Gonçalves, Gabriela Guedes Nascimento, Kethely Lima Marques, Barbara Conceição Costa Azeredo de Oliveira, Yure Bazilio dos Santos, Maria Eduarda Barros de Andrade, Karine Simões Calumbi, Eduardo Perdigão Maia, and et al. 2025. "Cannabigerol Modulates Cannabinoid Receptor Type 2 Expression in the Spinal Dorsal Horn and Attenuates Neuropathic Pain Models" Pharmaceuticals 18, no. 10: 1508. https://doi.org/10.3390/ph18101508

Rezende, B., Fernandes, G. G., de Simas Gonçalves, V. M., Nascimento, G. G., Marques, K. L., de Oliveira, B. C. C. A., dos Santos, Y. B., de Andrade, M. E. B., Calumbi, K. S., Maia, E. P., Trefilio, L. M., Antunes, F., Fontes-Dantas, F. L., & Montes, G. C. (2025). Cannabigerol Modulates Cannabinoid Receptor Type 2 Expression in the Spinal Dorsal Horn and Attenuates Neuropathic Pain Models. Pharmaceuticals, 18(10), 1508. https://doi.org/10.3390/ph18101508